Skip to content

Scott Stibitz

Scott Stibitz

Company: FDA

Job title: Chief, Laboratory of Mucosal Pathogens & Cellular Immunology

Bio:

Scott Stibitz obtained his Ph.D. in 1983 at the University of Wisconsin, Madison working in the laboratories of Julian Davies and William Reznikoff on antibiotic resistance transposons. He next pursued post-doctoral studies under Stanley Falkow at Stanford University. It was there that he began studying the molecular genetics of virulence gene regulation in Bordetella pertussis. Since joining the FDA in 1987, in addition to B. pertussis, he has initiated research projects on the genetic analysis of Bacillus anthracis and Staphylococcus aureus, improved testing of live biotherapeutic products, and bacteriophage therapy. He is currently chief of the Laboratory of Mucosal Pathogens and Cellular Immunology (LMPCI/DBPAP/OVRR/CBER) and oversees its regulatory activities. The regulatory portfolio of LMPCI includes vaccines against bacterial infectious diseases and malaria, as well as live biotherapeutic products, fecal microbiota for transplantation, and bacteriophage therapy.

Seminars:

Panel Discussion 1:00 pm

Read more

day: Day One

FDA Perspectives on Chemistry, Manufacturing, and Control for Bacteriophage Therapy Products 11:30 am

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.